Electrophysiological Data Needed To Determine ICD Benefit – NEJM Editorial
This article was originally published in The Gray Sheet
Executive Summary
The cost-effectiveness of expanded indications for implantable cardioverter defibrillators may pose a barrier to reimbursement by CMS, a New England Journal of Medicine editorial suggests
You may also be interested in...
Guidant Seeks Broader Medicare Coverage For Prophylactic ICDs
Guidant has asked CMS to expand coverage of implantable cardioverter defibrillators to include prophylactic implantation of ICDs, an indication supported by the results of the landmark MADIT II study, the agency announced May 30
Guidant Seeks Broader Medicare Coverage For Prophylactic ICDs
Guidant has asked CMS to expand coverage of implantable cardioverter defibrillators to include prophylactic implantation of ICDs, an indication supported by the results of the landmark MADIT II study, the agency announced May 30
Cardiologist Groups Guard Medicare ICD Payments From Physician Fee Cuts
Cardiologists are trying to guarantee that projected cost increases associated with internal cardioverter defibrillation implant procedures will not be offset by further cuts in Medicare payments to physicians